NewGen Issues Clarification on Press Release Titled NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director dated February 20, 2025
February 20, 2025 16:30 ET | Source: NewGenIvf Limited BANGKOK, Feb. 21,…
CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds…
SEALSQ NASDAQ QUANTUM DAY: Industry Expert Discussions on the Path to Technology Sovereignty in the U.S.
February 13, 2025 16:05 ET | Source: SEALSQ Geneva, Switzerland, Feb. 13,…
Odysight.ai Announces the Pricing of $21.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
Odysight.ai common stock to begin trading on Nasdaq Tuesday, February 11, 2025,…
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:30 ET | Source: Tempest Therapeutics BRISBANE, Calif., Feb.…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:30 ET | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:30 ET | Source: Neuronetics MALVERN, Pa., Feb. 07,…
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:05 ET | Source: Mersana Therapeutics, Inc. CAMBRIDGE, Mass.,…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, the…
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq:…